Exhibit 99.1
Press Release www.shire.com
|  |
Director/PDMR Shareholding
September 30, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”)
Notification of transactions by persons discharging managerial responsibilities
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Susan Kilsby | |
| 2. | Reason for the notification | ||
| a) | Position / status | Chairman - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Kilsby’s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 150 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | NASDAQ Global Select Market | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | |
| a) | Name | William Burns |
| 2. | Reason for the notification | ||
| a) | Position / status | Senior Independent Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
| |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Burns’ total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £50.10 | 139 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | London Stock Exchange (XLON) | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | |
| a) | Name | Dominic Blakemore |
| 2. | Reason for the notification | |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
| |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Blakemore’s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £50.10 | 133 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | London Stock Exchange (XLON) | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Olivier Bohuon | |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
| |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Bohuon’s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £50.10 | 131 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) |
| e) | Date of the transaction | September 30, 2016 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Gail Fosler | |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Fosler’s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 49 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | NASDAQ Global Select Market | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | |
| a) | Name | Steven Gillis |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”)
| |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Gillis’ total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 48 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | NASDAQ Global Select Market | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | |
| a) | Name | David Ginsburg |
| 2. | Reason for the notification | |
| a) | Position / status | Non-Executive Director - PDMR |
| b) | Initial notification / amendment | Initial notification |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Shire plc |
| b) | LEI | 54930005LQRLI2UXRQ59 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Ginsburg’s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 47 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | NASDAQ Global Select Market | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Sara Mathew | |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”) | |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Mathew’s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 46 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) |
| e) | Date of the transaction | September 30, 2016 |
| f) | Place of the transaction | NASDAQ Global Select Market |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | ||
| a) | Name | Anne Minto | |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each (“Ordinary Shares”)
| |
| Identification code | ISIN: JE00B2QKY057 | ||
| b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Ms. Minto’s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £50.10 | 138 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | London Stock Exchange (XLON) | |
| 1. | Details of the person discharging managerial responsibilities (“PDMR”) / person closely associated with them (“PCA”) | |
| a) | Name | Albert Stroucken |
| 2. | Reason for the notification | ||
| a) | Position / status | Non-Executive Director - PDMR | |
| b) | Initial notification / amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Shire plc | |
| b) | LEI | 54930005LQRLI2UXRQ59 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares (“ADSs”)
| |
| Identification code | ISIN: US82481R1068 | ||
| b) | Nature of the transaction | Acquisition of ADSs, being the part of Mr. Stroucken’s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2016. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| $194.99 | 53 | ||
| d) | Aggregated information
- Aggregated volume
- Price | N/A (single transaction) | |
| e) | Date of the transaction | September 30, 2016 | |
| f) | Place of the transaction | NASDAQ Global Select Market | |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
| Investor Relations | ||
| Sarah Elton-Farr | seltonfarr@shire.com | +44 1256 894157 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
www.shire.com